Chemotherapy Plus Concomitant Low-Dose Fractionated Radiotherapy as Second-Line Treatment for Recurrent or Progressive Glioblastoma After Temozolomide-Based Chemoradiation: A Pilot Study.

Journal of Clinical Oncology - United States
doi 10.1200/jco.2011.29.15_suppl.2083
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)


Related search